Cliff Asness's QGEN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 353,579 shares of Qiagen N.V. (QGEN) worth $14.19 M, representing 0.01% of the portfolio. First purchased in 2017-Q1, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in QGEN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 500,290 shares. Largest reduction occurred in Q4 2019, reducing 1.44 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Qiagen NV (QGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Qiagen NV (QGEN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -24,514 | Reduce 6.48% | 353,579 | $40.14 |
| Q4 2025 | +274,727 | Add 265.78% | 378,093 | $47.75 |
| Q3 2025 | -30,205 | Reduce 22.61% | 103,366 | $47.03 |
| Q2 2025 | -35,933 | Reduce 21.20% | 133,571 | $50.59 |
| Q1 2025 | +169,504 | New Buy | 169,504 | $42.26 |
| Q1 2024 | -109,053 | Sold Out | 0 | $0.00 |
| Q4 2023 | -72,820 | Reduce 40.04% | 109,053 | $48.50 |
| Q3 2023 | +18,549 | Add 11.36% | 181,873 | $45.23 |
| Q2 2023 | +49,478 | Add 43.46% | 163,324 | $50.29 |
| Q1 2023 | -7,460 | Reduce 6.15% | 113,846 | $51.29 |
| Q4 2022 | +58,193 | Add 92.20% | 121,306 | $55.69 |
| Q3 2022 | -6,278 | Reduce 9.05% | 63,113 | $46.09 |
| Q2 2022 | +6,340 | Add 10.06% | 69,391 | $52.72 |
| Q1 2022 | -27,436 | Reduce 30.32% | 63,051 | $54.72 |
| Q4 2021 | -47,499 | Reduce 34.42% | 90,487 | $62.06 |
| Q3 2021 | -20,029 | Reduce 12.68% | 137,986 | $57.71 |
| Q2 2021 | -210,915 | Reduce 57.17% | 158,015 | $54.03 |
| Q1 2021 | -5,825 | Reduce 1.55% | 368,930 | $54.37 |
| Q4 2020 | +41,640 | Add 12.50% | 374,755 | $59.02 |
| Q3 2020 | +321,428 | Add 2750.30% | 333,115 | $58.36 |
| Q2 2020 | -106,853 | Reduce 90.14% | 11,687 | $47.83 |
| Q1 2020 | -105,253 | Reduce 47.03% | 118,540 | $46.46 |
| Q4 2019 | -1.44 M | Reduce 86.53% | 223,793 | $37.74 |
| Q3 2019 | -439,193 | Reduce 20.91% | 1.66 M | $36.70 |
| Q2 2019 | -229,010 | Reduce 9.83% | 2.1 M | $44.99 |
| Q1 2019 | +219,443 | Add 10.40% | 2.33 M | $45.17 |
| Q4 2018 | +13,151 | Add 0.63% | 2.11 M | $38.46 |
| Q3 2018 | -28,461 | Reduce 1.34% | 2.1 M | $42.30 |
| Q2 2018 | -37,292 | Reduce 1.72% | 2.13 M | $40.74 |
| Q1 2018 | +334,823 | Add 18.32% | 2.16 M | $36.08 |
| Q4 2017 | +346,534 | Add 23.40% | 1.83 M | $34.55 |
| Q3 2017 | +279,677 | Add 23.28% | 1.48 M | $35.18 |
| Q2 2017 | +500,290 | Add 71.34% | 1.2 M | $37.44 |
| Q1 2017 | +701,228 | New Buy | 701,228 | $32.36 |
Cliff Asness's Qiagen NV Investment FAQs
Cliff Asness first purchased Qiagen N.V. (QGEN) in Q1 2017, acquiring 701,228 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Qiagen N.V. (QGEN) for 34 quarters since Q1 2017.
Cliff Asness's largest addition to Qiagen N.V. (QGEN) was in Q1 2017, adding 701,228 shares worth $22.69 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 353,579 shares of Qiagen N.V. (QGEN), valued at approximately $14.19 M.
As of the Q1 2026 filing, Qiagen N.V. (QGEN) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Qiagen N.V. (QGEN) was 2,329,393 shares, as reported at the end of Q1 2019.